Results 111 to 120 of about 2,128 (126)

A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma

European Journal of Cancer, 2014
Jennifer E Gains, Mark N Gaze
exaly  

High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during 131I-meta-iodobenzylguanidine treatment in children with neuroblastoma

Cancer, 2002
Hanneke Margo van Santen
exaly  

Assessment of Cardiac Sympathetic Nerve Function Using ¹²³I-meta-Iodobenzylguanidine Scintigraphy

Annals of Nuclear Cardiology, 2015
Shinro Matsuo, Kenichi Nakajima
exaly  

Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy

Journal of the Neurological Sciences, 1998
Mitsuhiro Yoshita
exaly  

Meta-Iodobenzylguanidine Scintigraphy in Neuroblastoma–a Comparison with Conventional X-Ray and Ultrasound

Pediatric Hematology and Oncology, 1986
exaly  

Tumor Dosimetry Using [124I]m-iodobenzylguanidine MicroPET/CT for [131I]m-iodobenzylguanidine Treatment of Neuroblastoma in a Murine Xenograft Model

Molecular Imaging and Biology, 2012
Youngho Seo, Chang-Lae Lee, Katherine K Matthay   +2 more
exaly  

Diagnosis and treatment of malignant pheochromocytoma with 131I-meta-iodobenzylguanidine: a case report

Radiotherapy and Oncology, 1990
exaly  

SPECIFICITY OF IODOBENZYLGUANIDINE SCANNING IN NEUROBLASTOMA

Lancet, The, 1988
exaly  

IODOBENZYLGUANIDINE FOR LOCATION AND TREATMENT OF PHAEOCHROMOCYTOMA

Lancet, The, 1984
exaly  

Meta-iodobenzylguanidine inhibits complex I and III of the respiratory chain in the human cell line molt-4

Biochemical Pharmacology, 1995
exaly